Article 199 The constitutional application for bioequivalence / bioavailability (BEBA) applicants was a pharmaceutical company and its complaint was that no laboratory was willing to test anti-TB drugs manufactured by it. ? For a drug that is necessary to prevent a dangerous disease and must be readily available at all costs, at affordable prices. The High Court expressed concern that within a few minutes of the committee, there is no document in which the four bodies have been recognized or otherwise empowered. To test and observe that in order to make the federal government's decision effective and beneficial, it was necessary that a formal instrument recognizing the four institutions be conducted by the agencies approved for conducting the BE / BA test. As such, it was important to recognize that the ability to manufacture domestic drugs, which is essential and would reduce the prices of medicines available for public use, empowered and supported them to provide essential medicines at all levels of society. Yes. The High Court directed the authorities to issue the necessary notification before the end of this financial year, under which the application will be dealt with.
Related judgments — Lahore High Court Lahore, 2012
